The presented molecular analysis of the binding of dexamethasone to serum albumin in combination with the risk factors identified from the clinical data analyzed here and elsewhere offer promising strategies for maximizing the effectiveness of dexamethasone in the treatment of severe COVID-19. The gene discussed is ALB; the disease is COVID-19.